We are live on ! Find out more
ANAB icon

AnaptysBio

113 hedge funds and large institutions have $675M invested in AnaptysBio in 2023 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 35 increasing their positions, 36 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more call options, than puts

Call options by funds: $1.47M | Put options by funds: $1.34M

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

3% less repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 36

4% less funds holding

Funds holding: 118113 (-5)

4.51% less ownership

Funds ownership: 115.64%111.13% (-4.5%)

25% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 20

32% less capital invested

Capital invested by funds: $990M → $675M (-$314M)

Holders
113
Holders Change
-5
Holders Change %
-4.24%
% of All Funds
1.8%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
15
Increased
35
Reduced
36
Closed
20
Calls
$1.47M
Puts
$1.34M
Net Calls
+$135K
Net Calls Change
+$64K
Name Holding Trade Value Shares
Change
Change in
Stake
VOYA Investment Management
126
VOYA Investment Management
Georgia
-$257K -8,281 Closed
Manulife (Manufacturers Life Insurance)
127
Manulife (Manufacturers Life Insurance)
Ontario, Canada
-$251K -8,085 Closed
IFWM
128
Institute for Wealth Management
Colorado
-$250K -8,055 Closed
FAM
129
Fred Alger Management
New York
-$191K -6,177 Closed
Allspring Global Investments
130
Allspring Global Investments
North Carolina
-$27.3K -880 Closed
Carson Wealth (CWM LLC)
131
Carson Wealth (CWM LLC)
Nebraska
+$486 +20 New

ANAB Hedge Fund Activity: Q1 2023 in Review

113 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in AnaptysBio (ANAB) for Q1 2023, worth a combined $675M — down 32% from $990M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of ANAB and 15 opened new positions — a net loss of 5 holders — while 36 trimmed existing stakes and 35 added.

The largest buyer was Great Point Partners, adding an estimated $19.2M. The largest seller was Federated Hermes, cutting an estimated $25.1M.

  • 113 institutional investors held AnaptysBio (ANAB) as of Q1 2023, down from 118 in Q4 2022.
  • Funds reported $675M of AnaptysBio stock for Q1 2023, down 32% quarter-over-quarter.
  • 15 funds opened new AnaptysBio positions in Q1 2023 and 20 closed out, a net change of -5 holders.
  • The largest AnaptysBio buyer in Q1 2023 was Great Point Partners, an estimated $19.2M added.
  • The largest AnaptysBio seller in Q1 2023 was Federated Hermes, an estimated $25.1M sold.

Based on aggregated 13F filings for Q1 2023.